2016 WHO classification of mature, aggressive TCLs
| PTCL-NOS |
| Nodal lymphomas of TFH-cell origin, including AITL |
| ALCL, ALK+ and ALK− |
| ATLL: acute and lymphomatous |
| Extranodal T-NK-cell lymphoma, nasal type |
| Intestinal TCL: EATL and monomorphic epitheliotropic intestinal TCL |
| Hepatosplenic TCL |
| Primary cutaneous CD8+ aggressive epidermotropic cytotoxic TCL |
| Breast implant–associated ALCL: extended disease beyond the capsule (stages II- IV) |
| PTCL-NOS |
| Nodal lymphomas of TFH-cell origin, including AITL |
| ALCL, ALK+ and ALK− |
| ATLL: acute and lymphomatous |
| Extranodal T-NK-cell lymphoma, nasal type |
| Intestinal TCL: EATL and monomorphic epitheliotropic intestinal TCL |
| Hepatosplenic TCL |
| Primary cutaneous CD8+ aggressive epidermotropic cytotoxic TCL |
| Breast implant–associated ALCL: extended disease beyond the capsule (stages II- IV) |
ATLL, adult T-cell leukemia/lymphoma; EATL, enteropathy-associated TCL; MEITL, monomorphic epitheliotropic intestinal TCL.